Ország: Írország
Nyelv: angol
Forrás: HPRA (Health Products Regulatory Authority)
Citalopram hydrobromide
Accord Healthcare Ireland Ltd.
N06AB; N06AB04
Citalopram hydrobromide
20 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Selective serotonin reuptake inhibitors; citalopram
Marketed
2006-03-10
PACKAGE LEAFLET: INFORMATION FOR THE USER CITALOPRAM 10 MG FILM-COATED TABLETS CITALOPRAM 20 MG FILM-COATED TABLETS Citalopram (as hydrobromide) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT CITALOPRAM IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CITALOPRAM 3. HOW TO TAKE CITALOPRAM 4. 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE CITALOPRAM 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT CITALOPRAM IS AND WHAT IT IS USED FOR Citalopram is a Selective Serotonin Reuptake Inhibitor (SSRI) and belongs to a group of medicines known as antidepressants. These medicines help to normalise the levels of serotonin in the brain. Disturbances in the serotonin system of the brain are key factors in the development of depression and related disorders. Citalopram is used for the treatment of depression (including the prevention of the recurrence of symptoms) and panic disorders in adults. _Depression _ is characterised by low/depressed mood, lack of energy, melancholia, feelings of little or no worth, sleeping disorders, withdrawal and being unable to cope with daily tasks. Depression may also be accompanied by suicidal thoughts. Depressed patients may further suffer from symptoms of anxiety. _Panic disorder _ is characterised by patients developing unexpected attacks of intense panic or anxiety when faced with particular situations or due to the fear of experiencing new attacks. Precisely what triggers the attacks varies from patient to patient. The attacks recur when the pat Olvassa el a teljes dokumentumot
Health Products Regulatory Authority 15 July 2021 CRN00C943 Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Citalopram 20 mg Film-coated tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 mg of Citalopram (as hydrobromide). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. White, circular, coated, biconvex, scored on both sides with side scores. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of depressive illness in the initial phase and as maintenance against potential relapse/recurrence in adults. Citalopram is also indicated in the treatment of panic disorder with or without agoraphobia in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Treating depression Adults_ The recommended starting dose is a single oral dose of 20 mg per day. Depending on individual patient response, the dose may be increased to a maximum of 40 mg daily. Following treatment initiation, an antidepressant effect should not be expected for at least two weeks. Treatment should continue until the patient has been free of symptoms for 4-6 months. In patients with recurrent depression (unipolar) maintenance therapy may need to be continued for a number of years to prevent new episodes. Citalopram should be withdrawn slowly; it is advised that the dose is gradually reduced over 1-2 week periods. _Treating Panic Disorder Adults_ A single oral dose of 10 mg daily is recommended for the first week before increasing the dose to 20 mg daily. Dependent on individual patient response, the dose may be increased to a maximum of 40 mg daily. Duration of treatment: Maximum effectiveness of Citalopram in treating panic disorder is reached after about 3 months and the response is maintained during continued treatment. _Elderly patients (>65 years of age)_ For elderly patients the dose should be decreased to half of the recommended dose, e.g 10-20 mg per day. The recommended maximum dose for th Olvassa el a teljes dokumentumot